5b-cholestanol
5b-cholestanol structure
|
Common Name | 5b-cholestanol | ||
|---|---|---|---|---|
| CAS Number | 516-92-7 | Molecular Weight | 388.669 | |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 455.5±13.0 °C at 760 mmHg | |
| Molecular Formula | C27H48O | Melting Point | N/A | |
| MSDS | USA | Flash Point | 190.7±12.3 °C | |
Use of 5b-cholestanolEpicoprostanol is the compound found in adipocere[1]. |
| Name | Epicoprostanol |
|---|---|
| Synonym | More Synonyms |
| Description | Epicoprostanol is the compound found in adipocere[1]. |
|---|---|
| Related Catalog | |
| References |
[2]. Na Yang, et al. HMPL-523, a Novel SYK Inhibitor, Showed Anti-tumor Activities in Vitro and in Vivo. |
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 455.5±13.0 °C at 760 mmHg |
| Molecular Formula | C27H48O |
| Molecular Weight | 388.669 |
| Flash Point | 190.7±12.3 °C |
| Exact Mass | 388.370514 |
| PSA | 20.23000 |
| LogP | 10.22 |
| Vapour Pressure | 0.0±2.5 mmHg at 25°C |
| Index of Refraction | 1.504 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
CAS#:601-53-6
CAS#:57-88-5
CAS#:10035-10-6
CAS#:64-19-7
CAS#:64-17-5
CAS#:67-63-0
CAS#:141-52-6|
Sterol Composition in Infant Formulas and Estimated Intake.
J. Agric. Food Chem. 63 , 7245-51, (2015) Sterol contents in infant formulas (IFs) from the European market were determined, and their intakes by infants between 0 and 6 months were evaluated. Total animal sterols (mg/100 mL) ranged from 1.71... |
|
|
An integrated evaluation of molecular marker indices and linear alkylbenzenes (LABs) to measure sewage input in a subtropical estuary (Babitonga Bay, Brazil).
Environ. Pollut. 188 , 71-80, (2014) Babitonga Bay is a South Atlantic estuary with significant ecological function; it is part of the last remaining areas of mangrove communities in the Southern Hemisphere. The aim of this study was to ... |
|
|
Serum plant sterols, cholestanol, and cholesterol precursors associate with histological liver injury in pediatric onset intestinal failure.
Am. J. Clin. Nutr. 100(4) , 1085-94, (2014) Increased serum concentrations of plant sterols, including stigmasterol, during parenteral nutrition (PN) have been linked with serum biochemical signs of intestinal failure-associated liver disease (... |
| b-Cholestanol |
| 5a-Cholestan-3b-ol |
| (5α)-cholestan-3β-ol |
| 5a-Dihydrocholesterol |
| (3S,5S,8R,9S,10S,13R,14S,17R)-10,13-Dimethyl-17-[(2R)-6-methyl-2-heptanyl]hexadecahydro-1H-cyclopenta[a]phenanthren-3-ol |
| 5α-Cholestan-3β-ol |
| (3β,5α)-Cholestan-3-ol |
| β-Cholestanol |
| 3b-Hydroxy-5a-cholestane |
| 3β-Hydroxy-5α-cholestane |
| Cholestan-3-ol, (3β,5α)- |
| 5α-Dihydrocholesterol |
| .α.-Coprostanol |
| cholestanol |
| (3b,5a)-Cholestan-3-ol |
| Cholestanol (VAN) |
| (3S,5S,8R,9S,10S,13R,14S,17R)-10,13-Diméthyl-17-[(2R)-6-méthyl-2-heptanyl]hexadécahydro-1H-cyclopenta[a]phénanthrén-3-ol |